Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Wesolowski

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
Arxiv|October 14, 2024
Computational Pathology for Accurate Prediction of Breast Cancer Recurrence: Development and Validation of a Deep Learning-based ToolZiyu Su, Yongxin Guo, Robert Wesolowski, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 18, 2025
Computational Pathology for Accurate Prediction of Breast Cancer Recurrence: Development and Validation of a Deep Learning-Based ToolZiyu Su, Yongxin Guo, Robert Wesolowski, et al.
Plos One|April 4, 2023
BCR-Net: A deep learning framework to predict breast cancer recurrence from histopathology imagesZiyu Su, Muhammad Khalid Khan Niazi, Thomas E Tavolara, et al.
NPJ Breast Cancer|April 16, 2026
Acute circulating tumor DNA dynamics during and after systemic therapy initiation for advanced triple-negative breast cancerBriana To, Vishnu Prasath, Deloris Veney, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 21, 2013
Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature reviewMing J Poi, Michael Berger, Maryam Lustberg, et al.
The Breast Journal|September 20, 2018
PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancerYanjun Hou, Hiroaki Nitta, Lai Wei, et al.
Computer Methods and Programs in Biomedicine|September 11, 2025
BPMambaMIL: A bio-inspired prototype-guided multiple instance learning for oncotype DX risk assessment in histopathologyYongxin Guo, Ziyu Su, Onur C Koyun, et al.
Drug Design, Development and Therapy|May 23, 2020
Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical DevelopmentBrooke Benner, Logan Good, Dionisia Quiroga, et al.
Frontiers in Oncology|May 6, 2022
Augmentation of Extracellular ATP Synergizes With Chemotherapy in Triple Negative Breast CancerJasmine M Manouchehri, Jharna Datta, Natalie Willingham, et al.
Investigational New Drugs|March 20, 2019
A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody-drug conjugate, in patients with breast cancer and other advanced solid tumorsLee S Rosen, Robert Wesolowski, Raffaele Baffa, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
Arxiv|October 14, 2024
Computational Pathology for Accurate Prediction of Breast Cancer Recurrence: Development and Validation of a Deep Learning-based ToolZiyu Su, Yongxin Guo, Robert Wesolowski, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 18, 2025
Computational Pathology for Accurate Prediction of Breast Cancer Recurrence: Development and Validation of a Deep Learning-Based ToolZiyu Su, Yongxin Guo, Robert Wesolowski, et al.
Plos One|April 4, 2023
BCR-Net: A deep learning framework to predict breast cancer recurrence from histopathology imagesZiyu Su, Muhammad Khalid Khan Niazi, Thomas E Tavolara, et al.
NPJ Breast Cancer|April 16, 2026
Acute circulating tumor DNA dynamics during and after systemic therapy initiation for advanced triple-negative breast cancerBriana To, Vishnu Prasath, Deloris Veney, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 21, 2013
Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature reviewMing J Poi, Michael Berger, Maryam Lustberg, et al.
The Breast Journal|September 20, 2018
PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancerYanjun Hou, Hiroaki Nitta, Lai Wei, et al.
Computer Methods and Programs in Biomedicine|September 11, 2025
BPMambaMIL: A bio-inspired prototype-guided multiple instance learning for oncotype DX risk assessment in histopathologyYongxin Guo, Ziyu Su, Onur C Koyun, et al.
Drug Design, Development and Therapy|May 23, 2020
Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical DevelopmentBrooke Benner, Logan Good, Dionisia Quiroga, et al.
Frontiers in Oncology|May 6, 2022
Augmentation of Extracellular ATP Synergizes With Chemotherapy in Triple Negative Breast CancerJasmine M Manouchehri, Jharna Datta, Natalie Willingham, et al.
Investigational New Drugs|March 20, 2019
A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody-drug conjugate, in patients with breast cancer and other advanced solid tumorsLee S Rosen, Robert Wesolowski, Raffaele Baffa, et al.
Pageof 14